Viscient Biosciences Proposes Merger to Unlock 3D Bioprinting Potential in Drug Discovery With Organovo
– Combined entity will enable significant developments in high-value indications beyond NASH blockbuster opportunity SAN DIEGO–(BUSINESS WIRE)–Viscient Biosciences (“Viscient”), a…